Once-daily vs twice-daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible: A randomized trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Once-daily vs twice-daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible: A randomized trial

Published:2018-11-08 Issue:12 Volume:32 Page:e13423
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Okumi Masayoshi¹^ORCID,Unagami Kohei²,Furusawa Miyuki¹,Kakuta Yoichi¹^ORCID,IIzuka Junpei¹,Takagi Toshio¹,Shirakawa Hiroki³,Shimizu Tomokazu⁴,Omoto Kazuya⁴,Inui Masashi⁵,Ishida Hideki¹,Tanabe Kazunari¹^ORCID

Affiliation:

1. Department of Urology; Tokyo Women’s Medical University; Tokyo Japan

2. Department of Nephrology; Tokyo Women’s Medical University; Tokyo Japan

3. Department of Urology; Ohkubo Hospital; Tokyo Japan

4. Department of Urology and Transplant Surgery; Toda Chuo General Hospital; Saitama Japan

5. Department of Urology, Yachiyo Medical Center; Tokyo Women’s Medical University; Chiba Japan

Funder

Astellas Pharma

Publisher

Wiley

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ctr.13423/fullpdf

Reference36 articles.

1. US Renal Data System 2014 Annual Data Report: epidemiology of kidney disease in the United States;Saran;Am J Kidney Dis,2015

2. Immunosuppression: evolution in practice and trends, 1994-2004;Meier-Kriesche;Am J Transplant,2006

3. Novel once-daily extended-release tacrolimus versus twice-daily tacrolimus in de novo kidney transplant recipients: two-year results of phase 3, double-blind, randomized trial;Rostaing;Am J Kidney Dis,2016

4. Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation;Weng;J Am Soc Nephrol,2005

5. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring;Kuypers;Transplantation,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term effects of average calcineurin inhibitor trough levels (over time) on renal function in a prospectively followed cohort of 150 kidney transplant recipients;Clinical and Translational Science;2023-10-10

2. Efficacy and safety of once-daily prolonged-release tacrolimus versus twice-daily tacrolimus in kidney transplant recipients: A meta-analysis and trial sequential analysis;Journal of the Chinese Medical Association;2023-07-17

3. Long‐term prolonged‐release tacrolimus outcomes in living donor kidney transplantation: The Japan Academic Consortium of Kidney Transplantation study‐II;International Journal of Urology;2023-02-16

4. Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials;Annals of Transplantation;2021-12-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3